News
Concizumab looks feasible in hemophilia A and B treatment
MELBOURNE – The monoclonal antibody concizumab has shown a favorable safety profile and significant reductions in bleeding for patients with...
News
Acid-suppressing drug use associated with increased antiallergy drug use
People taking acid-suppressing medications such as proton pump inhibitors are subsequently more likely to use anti-allergy drugs.
News
No increase in UTI risk with SGLT-2 inhibitors
compared...
News
RNA interference drug fitusiran looks effective in both hemophilia A and B
MELBOURNE – The RNA interference drug fitusiran is associated with significant reductions in bleeding rates in patients with hemophilia A and B,...
News
Early phase trial shows durable responses to gene therapy for hemophilia A
MELBOURNE – Gene therapy to replace factor VIII in patients with hemophilia has shown sustained reductions in bleeding rates with no significant...
News
Lichenoid dermatitis with mycosis fungoides features linked to checkpoint inhibitor therapy
A patient treated with immune checkpoint inhibitor therapy for thyroid carcinoma presented with lichenoid dermatitis with mycosis fungoides–like...
News
Air pollution levels correlated with cardiorespiratory mortality, reduced life expectancy
Fine particulate matter pollution is associated with increased cardiorespiratory mortality, particularly in lower-income areas.
News
Emicizumab follow-up shows further bleeding declines
MELBOURNE – Longer-term follow-up data with emicizumab in hemophilia A shows further declines in bleeding rates and improvement in target joints...
News
Minor surgeries appear safe for hemophilia patients on emicizumab
MELBOURNE – Patients with hemophilia A treated with emicizumab can safely undergo minor surgery, often without needing prophylactic coagulation...
News
Risk of atrial fibrillation 900% higher with cancer
MELBOURNE –
News
Subcutaneous marstacimab appears safe in hemophilia A and B
MELBOURNE – Subcutaneous marstacimab produced significant reductions in bleeding rates in hemophilia A and B with reasonable safety and...
News
No reduction in PE risk with vena cava filters after severe injury
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
News
Consider bleeding risk with oral anticoagulants in patients with GI cancer
MELBOURNE – Patients with some GI cancers may be at increased risk of bleeding, which can complicate the choice of antithrombotic therapies.